185 related articles for article (PubMed ID: 1420290)
1. Effects of 2-tetradecylglycidic acid on rat platelet energy metabolism and aggregation.
Ishikura H; Takeyama N; Tanaka T
Biochim Biophys Acta; 1992 Oct; 1128(2-3):193-8. PubMed ID: 1420290
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet aggregation and fatty acid oxidation in diabetic rats.
Iida N; Iida R; Takeyama N; Tanaka T
Biochem Mol Biol Int; 1993 May; 30(1):177-85. PubMed ID: 8358330
[TBL] [Abstract][Full Text] [Related]
3. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid (TDGA) on glucose and fatty acid oxidation in isolated rat soleus muscle.
Tuman RW; Joseph JM; Brentzel HJ; Tutwiler GF
Int J Biochem; 1988; 20(2):155-60. PubMed ID: 3350201
[TBL] [Abstract][Full Text] [Related]
4. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
Brady PS; Brady LJ
Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia alters the energy metabolism and aggregation of washed human platelets.
Akahori M; Uedono Y; Yamagami K; Takeyama N; Kitazawa Y; Tanaka T
Haematologia (Budap); 1995; 26(4):191-8. PubMed ID: 7590513
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the energetics of platelet responses induced by different agonists.
Verhoeven AJ; Mommersteeg ME; Akkerman JW
Biochem J; 1986 Jun; 236(3):879-87. PubMed ID: 3098241
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone.
Durand P; Bloy C; Peltier-Pujol F; Blache D
J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488
[TBL] [Abstract][Full Text] [Related]
8. Adenylate energy charge of rat and human cultured hepatocytes.
Matsui Y; Kitade H; Kamiya T; Kanemaki T; Hiramatsu Y; Okumura T; Kamiyama Y
In Vitro Cell Dev Biol Anim; 1994 Sep; 30A(9):609-14. PubMed ID: 7820312
[TBL] [Abstract][Full Text] [Related]
9. Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes.
Skorin C; Necochea C; Johow V; Soto U; Grau AM; Bremer J; Leighton F
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):561-7. PubMed ID: 1736904
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover.
Arduini A; Denisova N; Virmani A; Avrova N; Federici G; Arrigoni-Martelli E
J Neurochem; 1994 Apr; 62(4):1530-8. PubMed ID: 8133280
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
Willoughby SR; Chirkov YY; Kennedy JA; Murphy GA; Chirkova LP; Horowitz JD
Eur J Pharmacol; 1998 Sep; 356(2-3):207-13. PubMed ID: 9774251
[TBL] [Abstract][Full Text] [Related]
13. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
14. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
Holmsen H; Day HJ; Setkowsky CA
Biochem J; 1972 Aug; 129(1):67-82. PubMed ID: 4675006
[TBL] [Abstract][Full Text] [Related]
15. [Effect of calcium, thrombin and nucleotides (ADP, cAMP, cGMP) on blood platelet glycolysis and energy metabolism].
Nikulin AA
Farmakol Toksikol; 1980; 43(5):585-90. PubMed ID: 6256208
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva.
Smal MA; Baldo BA
Platelets; 2022 May; 33(4):562-569. PubMed ID: 34348059
[TBL] [Abstract][Full Text] [Related]
17. Glyoxylate lowers metabolic ATP in human platelets without altering adenylate energy charge or aggregation.
Dangelmaier CA; Holmsen H
Platelets; 2014; 25(1):36-44. PubMed ID: 23488475
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
20. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
Hurst JS; Slater TF; Lang J; Juergens G; Zollner H; Esterbauer H
Chem Biol Interact; 1987 Feb; 61(2):109-24. PubMed ID: 3103933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
